- Home
- RFIL vs ANEB Comparison
RFIL vs ANEB Comparison
Compare RFIL & ANEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RFIL
- ANEB
- Stock Information
- Founded
- RFIL 1979
- ANEB 2020
- Country
- RFIL United States
- ANEB United States
- Employees
- RFIL N/A
- ANEB N/A
- Industry
- RFIL Electrical Products
- ANEB Biotechnology: Pharmaceutical Preparations
- Sector
- RFIL Technology
- ANEB Health Care
- Exchange
- RFIL Nasdaq
- ANEB Nasdaq
- Market Cap
- RFIL 39.9M
- ANEB 36.7M
- IPO Year
- RFIL N/A
- ANEB 2021
- Fundamental
- Price
- RFIL $3.82
- ANEB $1.01
- Analyst Decision
- RFIL Strong Buy
- ANEB Buy
- Analyst Count
- RFIL 1
- ANEB 1
- Target Price
- RFIL $4.50
- ANEB $8.00
- AVG Volume (30 Days)
- RFIL 38.1K
- ANEB 34.3K
- Earning Date
- RFIL 06-12-2025
- ANEB 05-14-2025
- Dividend Yield
- RFIL N/A
- ANEB N/A
- EPS Growth
- RFIL N/A
- ANEB N/A
- EPS
- RFIL N/A
- ANEB N/A
- Revenue
- RFIL $70,599,000.00
- ANEB N/A
- Revenue This Year
- RFIL $16.16
- ANEB N/A
- Revenue Next Year
- RFIL $5.75
- ANEB N/A
- P/E Ratio
- RFIL N/A
- ANEB N/A
- Revenue Growth
- RFIL 4.93
- ANEB N/A
- 52 Week Low
- RFIL $2.86
- ANEB $0.80
- 52 Week High
- RFIL $5.77
- ANEB $3.30
- Technical
- Relative Strength Index (RSI)
- RFIL 40.43
- ANEB 39.13
- Support Level
- RFIL $3.76
- ANEB $0.94
- Resistance Level
- RFIL $4.17
- ANEB $1.12
- Average True Range (ATR)
- RFIL 0.30
- ANEB 0.13
- MACD
- RFIL -0.05
- ANEB -0.01
- Stochastic Oscillator
- RFIL 28.48
- ANEB 22.00
About RFIL RF Industries Ltd.
RF Industries Ltd is engaged in the design, manufacture, and marketing of interconnect products and systems, including coaxial and specialty cables, fiber optic cables and connectors, and electrical and electronic specialty cables. The company operates through two segments: RF Connector and Cable Assembly, which consists of the Connector and Cable Assembly Division, and Custom Cabling Manufacturing and Assembly, which consists of its subsidiaries. The company has operations in the United States, Canada, Israel, and Mexico.
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.